Join us at Illumination 2024!
Posters, Merch & More
VIEW ITEMSAbout Illumination
An Immersive Light Art Experience... The Clayco Foundation is determined to find a cure for Retinal Vasculopathy with Cerebral Leukodystrophy (RVCL). RVCL is a rare and fatal genetic condition affecting the central nervous system, causing the deterioration of small blood vessels in the brain and eyes of those affected. Most patients begin experiencing vision loss and strokes in their early 40s and have an average lifespan of eight years following their first symptoms. Rare disease affects nearly all of us. Thirty million people in the United States live with some form of the rare disease; that's close to 1 in 10 people. We believe that we can make a difference by building on last year's success. We look forward to your partnership and exceeding our goals in 2024.
Illumination 2023 Event Recap:
Illumination 2022 Event Recap:
The Clayco Foundation
The Clayco FoundationAbout The Clayco Foundation
The Clayco Foundation is a 501(c)(3) organization dedicated to educating and supporting patients, researchers, and doctors. Retinal Vasculopathy with Cerebral Leukoencephalopathy (RVCL) is a rare genetic disorder that causes progressive damage to the brain, eye, kidney, and liver. There is currently no cure for RVCL, something The Clayco Foundation aims to change.